Promoting Genuine Tobacco Products in Russia

Nov.22.2022
Promoting Genuine Tobacco Products in Russia
Alexei Sinitsyn, deputy chairman of the Economic Policy Committee of the Federation Council, called for the elimination of counterfeit tobacco products.

The First Deputy Chairman of the Economic Policy Committee of the Federation Council of Russia, Alexei Sinitsyn. Photo source: ВМЕСТЕ РФ.


In a news report from Federal Information Channel, Alexei Sinitsyn, the first deputy chairman of the Federal Committee's Economic Policy Committee, pointed out at a roundtable discussion specifically focused on the tobacco industry that counterfeit products must be eliminated from the domestic tobacco market.


According to him, despite various efforts made by the nation, the pace at which Russians quit smoking remains slow. Data from Rosstat (Federal State Statistics Service) shows that over 20% of Russian adults smoke, a figure which has remained unchanged for several years. Increasing prices will only make cigarettes more affordable.


The government's role is to establish regulations that will help to standardize the industry, or at least prevent it from entering a massive grey area. The industry's general issues have been repeatedly discussed in various locations, with the main problem being a significant difference in consumption tax rates between Russia and neighboring EAEU countries. SenatInformSinitsyn stated that the government has taken measures to address this issue, but many sectors of the Russian economy, including tobacco, are experiencing significant changes related to unfriendly countries' sanction policies this year.


According to data from Rosstat, the production of legal cigarettes decreased by over 17% in the first half of this year. Meanwhile, the percentage of counterfeit cigarettes is on the rise. According to data from the Ministry of Industry and Trade, over 12% of cigarettes in the country are now counterfeit, up from 11.5% a year ago. The resulting budget loss is estimated at 70 billion rubles, or roughly 8.2 billion yuan.


Statement:


This article compiles information from a third-party source and is intended for internal industry exchange and learning only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the contents of the article. The compilation of this article is solely for communication and research within the industry.


Due to limitations in translation ability, the article translation may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government regarding any domestic, Hong Kong, Macau and Taiwan-related, and foreign statements and positions.


Copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.
Sep.29
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
Japan Tobacco (JT) delivered a strong Q3 2025. Revenue rose 18.3% year over year to ¥947.2 billion, with adjusted operating profit up 27.8% to ¥279.0 billion (+20.8% at constant currency) and net profit up 29.7% to ¥176.7 billion. Growth was led by reduced-risk products (RRP): total RRP volume climbed 40%, with heated tobacco (HTS) up 53%. In Japan, the launches of Ploom AURA and EVO pods pushed HTS category share to 15.5%, while the Ploom user base has nearly doubled versus two years ago.
Oct.30 by 2FIRSTS.ai
Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts agrees to stop selling flavored disposable e-cigarettes in California as part of settlement with NJOY.
Oct.13 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Ireland’s Minister for Health, Jennifer Carroll MacNeill, will seek Cabinet approval today for the publication of the Public Health (Single-Use Vapes) Bill 2025, which proposes banning the retail sale of single-use or disposable vapes six months after becoming law. The measure aims to address the growing use of disposable vapes, particularly among young people, and close regulatory gaps around emerging nicotine products such as pouches.
Nov.18 by 2FIRSTS.ai